4China Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Guideline for diagnosis and treatment of patients with ST- elevation myocardial infarction [ J ]. Zhonghua Xin Xue Guan Bing Za Zhi, 2015, 43 (5) : 380 -393.
5Welsh RC, Van de Weft F, Westerhout CM, et al. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study) [J]. Am J Cardiol, 2014, 114 (6): 811 -819.
6Figueras J, Roca I, Barrab6s JA, et al. Long - term implications of further ST elevation during thrombolytic therapy on left ventrlcular function [J]. Coron Artery Dis, 2013, 24 (6): 455-460.
7SunY, Liu X, Guo L, et al. HTUPA as a new thrombolytic agent for acute myocardial infarction: a multicenter, randomized study [ J]. Int J Cardiol, 2014, 172 (2) : 326 -331.
8Bekler A, Altun B, Gazi E, et al. Comparison of the GRACE risk score and the TIMI risk index in predicting the extent and severity ofcoronary artery disease in patients with acute coronary syndrome [ J ]. Anadol J Cardiol, 2015, 15 (10) : 801 -806.
9Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST - elevation myocardial infarction : a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early I trial substudy [ J ]. Circulation. 2000. 102 (17): 2031-2037.
10Tamis -Holland JE, O'Gara P. Highlights from the 2013 ACCF /AHA guidelines for the management of ST - elevation myocardial infarction and beyond [ J]. Clin Cardiol, 2014, 37 (4): 252 - 259.
